Effect of Matricaria chamomilla Hydroalcoholic Extract on Cisplatin-induced Neuropathy in Mice

Chinese Journal of Natural Medicines

Volumn 9, Issue 2, 2011, Pages 126-131

  Abad, A Namvaran Abbas ^a   Nouri, M H Kayate ^a   Gharjanie, A ^b   Tavakoli, F ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cisplatin; Matricaria chamomilla; Mice; Pain

Indexed keywords

CISPLATIN; FORMALDEHYDE; MATRICARIA CHAMOMILLA EXTRACT; MORPHINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BITE; CONTROLLED STUDY; LICKING; MALE; MATRICARIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PERIPHERAL NEUROPATHY; RESPONSE TIME; SINGLE DRUG DOSE;

EID: 79956311342     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.3724/SP.J.1009.2011.00126     Document Type: Article

References (73)

1. Kelland L The resurgence of platinum-based cancer chemotherapy [J]. Nat Rev Cancer 2007, 7(8):573-584.
2. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study [J]. J Clin Oncol 2004, 22(2):229-237.
3. Bhagra A, Rao RD Chemotherapy-induced neuropathy [J]. Curr Oncol Rep 2007, 9(4):290-299.
4. Kannarkat G, Lasher EE, Schiff D Neurologic complications of chemotherapy agents [J]. Curr Opin Neurol 2007, 20(6):719-725.
5. Pan Y, Kao MS Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy [J]. Int J Gynecol Cancer 2007, 17(2):394-397.
6. Gamelin E, Gamelin L, Bossi L, et al. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures [J]. Semin Oncol 2002, 29(1):21-33.
7. Murata M, Yamaji Y, Futami H, et al. Peripheral neuropathy caused by cisplatin in patients with lung cancer [J]. Gan To Kagaku Ryoho 1989, 16(6):2283-2288.
8. Gauchan P, Andoh T, Ikeda K, et al. Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha (2) delta-1 subunit [J]. Biol Pharm Bull 2009, 32(4):732-734.
9. Ghirardi O, Lo Giudice P, Pisano C, et al. Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties [J]. Anticancer Res 2005, 25(4):2681-2687.
10. Grothey A Oxaliplatin-safety profile: neurotoxicity [J]. Semin Oncol 2003, 30(1):5-13.
11. Joseph EK, Chen X, Bogen O, et al. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy [J]. J Pain 2008, 9(5):463-472.
12. Lersch C, Schmelz R, Eckel F, et al. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer [J]. Clin Colorectal Cancer 2002, 2(1):54-58.
13. Ling B, Authier N, Balayssac D, et al. Behavioral and pharma-cological description of oxaliplatin-induced painful neuropathy in rat [J]. Pain 2007, 128(3):225-234.
14. Ling B, Coudore-Civiale MA, Balayssac D, et al. Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat [J]. Toxicology 2007, 234(3):176-184.
15. Ling B, Coudore F, Decalonne L, et al. Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection [J]. Neuropharmacology 2008, 55(5):724-728.
16. O'Hara M, Kiefer D, Farrell K, et al. A review of 12 commonly used medicinal herbs [J]. Arch Fam Med 1998, 7(6):523-536.
17. Berry M The chamomiles [J]. The Pharma J 1995, 254:191-193.
18. Kyokong O, Charuluxananan S, Muangmingsuk V, et al. Efficacy of chamomile-extract spray for prevention of postoperative sore throat[J]. J Med Assoc Thai 2002, 85(S1):180-185.
19. Mills S The Essential Book of Herbal Medicine [M] 1991, 677. Penguin Books Ltd., London, 23. 2nd ed.
20. Norman GB, Max W Herbal drugs and phytopharmaceuticals [M] 2001, 322-325. CRC Press, London. 2nd edition.
21. Trease GE, Evans WC Pharmacognosy [M] 1982, 225. Bailliere Tindall, London, 367, 483. 12th Edition.
22. Wong AH, Smith M, Boon HS Herbal remedies in psychiatric practice [J]. Arch Gen Psychiatry 1998, 55(11):1033-1044.
23. Merk Index [M]. 9th Edition. 1976, city?, Merk sharp and Dohme Limited, USA, 1861: 3277, 5587.
24. Varro ET, Lynn RB, James ER Pharmacognosy [M] 1988, 464-466. Lea & Fabigen, Philadelphia. 9th Edition.
25. Coderre TJ, Vaccarino AL, Melzack R Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection [J]. Brain Res 1990, 535(1):155-158.
26. Ivey KJ Gastrointestinal intolerance and bleeding with nonnarcotic analgesics [J]. Drugs 1986, 32(S4):71-89.
27. Murray MD, Brater DC Renal toxicity of the nonsteroidal anti-inflammatory drugs [J]. Annu Rev Pharmacol Toxicol 1993, 33:435-465.
28. Joseph EK, Levine JD Comparison of oxaliplatin-and cisplatin-induced painful peripheral neuropathy in the rat [J]. J Pain 2009, 10(5):534-541.
29. Shibata M, Ohkubo T, Takahashi H, et al. Modified formalin test: characteristic biphasic pain response [J]. Pain 1989, 38(3):347-352.
30. Aley KO, Levine JD Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat[J]. Neuroscience 2002, 111(2):389-397.
31. Joseph EK, Levine JD Caspase signalling in neuropathic and inflammatory pain in the rat[J]. Eur J Neurosci 2004, 20(11):2896-2902.
32. The Merck Index. An encyclopedia of chemicals, drugs, and biological [M] 1996, Merk Research Laboratories Publication.
33. Stillman M, Cata JP Management of chemotherapy-induced peripheral neuropathy [J]. Curr Pain Headache Rep 2006, 10(4):279-287.
34. Sul JK, Deangelis LM Neurologic complications of cancer chemotherapy [J]. Semin Oncol 2006, 33(3):324-332.
35. Eastman A Alkylating and platinum-based agents [J]. Curr Opin Oncol 1990, 2(6):1109-1114.
36. Reed E Alkylating agents and platinum: is clinical resistance simply a tumor cell phenomenon [J]. Curr Opin Oncol 1991, 3(6):1055-1059.
37. Rosenberg B Noble metal complexes in cancer chemotherapy [J]. Adv Exp Med Biol 1977, 91:129-150.
38. Cersosimo RJ Oxaliplatin-associated neuropathy: a review [J]. Ann Pharmacother 2005, 39(1):128-135.
39. Extra JM, Marty M, Brienza S, et al. Pharmacokinetics and safety profile of oxaliplatin [J]. Semin Oncol 1998, 25(1):13-22.
40. Culy CR, Clemett D, Wiseman LR Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies [J]. Drugs 2000, 60(4):895-924.
41. Sahley TL, Berntson GG Antinociceptive effects of central and systemic administrations of nicotine in the rat [J]. Psycho-pharmacology (Berl) 1979, 65(3):279-283.
42. Joseph EK, Chen X, Khasar SG, et al. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat [J]. Pain 2004, 107(1-2):147-158.
43. Joseph EK, Levine JD Mitochondrial electron transport in models of neuropathic and inflammatory pain [J]. Pain 2006, 121(1-2):105-114.
44. Adelsberger H, Quasthoff S, Grosskreutz J, et al. The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons [J]. Eur J Pharmacol 2000, 406(1):25-32.
45. Krishnan AV, Goldstein D, Friedlander M, et al. Oxaliplatin and axonal Na+ channel function in vivo[J]. Clin Cancer Res 2006, 12(15):4481-4484.
46. Binder A, Stengel M, Maag R, et al. Pain in oxaliplatin-induced neuropathy-sensitisation in the peripheral and central nociceptive system [J]. Eur J Cancer 2007, 43(18):2658-2663.
47. Kiernan MC, Krishnan AV The pathophysiology of oxaliplatin-induced neurotoxicity [J]. Curr Med Chem 2006, 13(24):2901-2907.
48. Krishnan AV, Goldstein D, Friedlander M, et al. Oxaliplatin-induced neurotoxicity and the development of neuropathy [J]. Muscle Nerve 2005, 32(1):51-60.
49. Garrido N, Perez-Martos A, Faro M, et al. Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels [J]. Biochem J 2008, 414(1):93-102.
50. Goodisman J, Hagrman D, Tacka KA, et al. Analysis of cytotoxicities of platinum compounds [J]. Cancer Chemother Pharmacol 2006, 57(2):257-267.
51. Heaney ML, Gardner JR, Karasavvas N, et al. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs [J]. Cancer Res 2008, 68(19):8031-8038.
52. Kim CH, Kang SU, Pyun J, et al. Epicatechin protects auditory cells against cisplatin-induced death [J]. Apoptosis 2008, 13(9):1184-1194.
53. Melli G, Taiana M, Camozzi F, et al. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy [J]. Exp Neurol 2008, 214(2):276-284.
54. Flatters SJ, Bennett GJ Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction [J]. Pain 2006, 122(3):245-257.
55. Osio M, Muscia F, Zampini L, et al. Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study [J]. J Peripher Nerv Syst 2006, 11(1):72-76.
56. Aceto MD, Tripathi BR, May HL, et al. Antinociceptive effects of the optically pure stereoisomers of nicotine [J]. Pharmacologist 1980, 22:302.
57. Phan DV, Doda M, Bite A, et al. Antin ociceptive activity of nicotine [J]. Acta Physiol Acad Sci Hung 1973, 44(1):85-93.
58. Besson JM, Chaouch A Peripheral and spinal mechanisms of nociception [J]. Physiol Rev 1987, 67(1):67-186.
59. Viola H, Wasowski C, de Stein M Levi, et al. Apigenin, a component of Matricaria recutita flowers, is a central benzo-diazepine receptors-ligand with anxiolytic effects [J]. Planta Med 1995, 61(3):213-216.
60. Nmecz G Herbal pharmacy: chamomile, this widely available herb has diverse therapeutic uses, including antiphlogistic, sedative and antimicrobial effects [J]. US Pharmacist 2000, 23:115-123.
61. Miller T, Wittstock U, Lindequist U, et al. Effects of some components of the essential oil of chamomile, Chamomilla recutita, on histamine release from rat mast cells [J]. Planta Med 1996, 62(1):60-61.
62. Gerritsen ME, Carley WW, Ranges GE, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression [J]. Am J Pathol 1995, 147(2):278-292.
63. Szelenyi I, Isaac O, Thiemer K Pharmacological experiments with compounds of chamomile. III. Experimental studies of the ulcerprotective effect of chamomile (author's transl) [J]. Planta Med 1979, 35(3):218-227.
64. Rekka EA, Kourounakis AP, Kourounakis PN Investigation of the effect of chamazulene on lipid peroxidation and free radical processes [J]. Res Commun Mol Pathol Pharmacol 1996, 92(3):361-364.
65. Carstens E, Wilson C Rat tail flick reflex: magnitude measurement of stimulus-response function, suppression by morphine and habituation [J]. J Neurophysiol 1993, 70(2):630-639.
66. Douglass DK, Carstens E Responses of rat sacral spinal neurons to mechanical and noxious thermal stimulation of the tail [J]. J Neurophysiol 1997, 77(2):611-620.
67. Einspahr FJ, Piercey MF Morphine depresses dorsal horn neuron responses to controlled noxious and non-noxious cutaneous stimulation [J]. J Pharmacol Exp Ther 1980, 213(3):456-461.
68. Wheatley D Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability [J]. J Psychopharmacol 2005, 19(4):414-421.
69. Kobayashi Y, Nakano Y, Inayama K, et al. Dietary intake of the flower extracts of German chamomile (Matricaria recutita L.) inhibited compound 48/80-induced itch-scratch responses in mice[J]. Phytomedicine 2003, 10(8):657-664.
70. Chevalier A The encyclopedia of medicinal plant [M] 1996, 54. Press?, London.
71. McCall WD, Tanner KD, Levine JD Formalin induces biphasic activity in C-fibers in the rat [J]. Neurosci Lett 1996, 208(1):45-48.
72. Ramos-e-Silva M, Ferreira AF, Bibas R, et al. Clinical evaluation of fluid extract of Chamomilla recutita for oral aphthae [J]. J Drugs Dermatol 2006, 5(7):612-617.
73. Burns E, Blamey C, Ersser SJ, et al. The use of aromatherapy in intrapartum midwifery practice an observational study [J]. Complement Ther Nurs Midwifery 2000, 6(1):33-34.